In December of 2022, the Mets signed Brandon Nimmo to an eight-year, $162 million deal that ensured he would likely be a Met for most if not all of his career. If there were any concerns about this commitment to the Mets’ 2011 first-round draft pick, they were likely related to durability. In his walk year in 2022, Nimmo played over 100 games in a season for just the second time in his career and put up his most valuable season, taking the first step to shed the dreaded “injury prone” label. But could he do it again?
With his second healthy season in a row, Brandon Nimmo demonstrated why he is a good long-term investment for the Mets
